{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:05:30Z","timestamp":1768874730244,"version":"3.49.0"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,4,15]]},"DOI":"10.2169\/internalmedicine.5143-20","type":"journal-article","created":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T22:09:13Z","timestamp":1605478153000},"page":"1257-1263","source":"Crossref","is-referenced-by-count":4,"title":["Diverse Pathological Findings of Interstitial Lung Disease in a Patient with Dyskeratosis Congenita"],"prefix":"10.2169","volume":"60","author":[{"given":"Ryota","family":"Otoshi","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Shintani","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideya","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukie","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Environmental Immuno-Dermatology, Yokohama City University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Hamanoue","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Yokohama City University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Mizuguchi","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Yokohama City University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomichi","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Yokohama City University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Okudela","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yokohama City University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamiko","family":"Takemura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood 107: 2680-2685, 20061."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Walne AJ, Marrone A, Dokal I. Dyskeratosis congenita: a disorder of defective telomere maintenance? Int J Hematol 82: 184-189, 2005.","DOI":"10.1532\/IJH97.05067"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Utz JP, Ryu JH, Myers JL, Michels VV. Usual interstitial pneumonia complicating dyskeratosis congenita. Mayo Clin Proc 80: 817-821, 2005.","DOI":"10.4065\/80.6.817"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Imokawa S, Sato A, Toyoshima M, et al. Dyskeratosis congenita showing usual interstitial pneumonia. Intern Med 33: 226-230, 1994.","DOI":"10.2169\/internalmedicine.33.226"},{"key":"5","unstructured":"5. Safa WF, Lestringant GG, Frossard PM. X-linked dyskeratosis congenita: restrictive pulmonary disease and a novel mutation. Thorax 56: 891-894, 2001."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 198: e44-e68, 2018.","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Ichida F, Tsuji T, Omata M, et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. International Hepatology Communications 6: 112-119, 1996.","DOI":"10.1016\/S0928-4346(96)00325-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol 110: 768-779, 2000.","DOI":"10.1046\/j.1365-2141.2000.02109.x"},{"key":"9","unstructured":"9. Kirwan M, Dokal I. Dyskeratosis congenita: a genetic disorder of many faces. Clin Genet 73: 103-112, 2008."},{"key":"10","unstructured":"10. Fern\u00e1ndez Garc\u00eda MS, Teruya-Feldstein J. The diagnosis and treatment of dyskeratosis congenita: a review. J Blood Med 21: 157-167, 2014."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nelson ND, Bertuch AA. Dyskeratosis congenita as a disorder of telomere maintenance. Mutat Res 730: 43-51, 2012.","DOI":"10.1016\/j.mrfmmm.2011.06.008"},{"key":"12","unstructured":"12. Knight S, Vulliamy T, Copplestone A, Gluckman E, Mason P, Dokal I. Dyskeratosis congenita (DC) registry: identification of new features of DC. Br J Haematol 103: 990-996, 1998."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yabe M, Yabe H, Hattori K, et al. Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation. Bone Marrow Transplant 19: 389-392, 1997.","DOI":"10.1038\/sj.bmt.1700674"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Paul SR, Perez-Atayde A, Williams DA. Interstitial pulmonary disease associated with dyskeratosis congenita. Am J Pediatr Hematol Oncol 14: 89-92, 1992.","DOI":"10.1097\/00043426-199221000-00015"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Borie R, Tab\u00e8ze L, Thabut G, et al. Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis. Eur Respir J 48: 1721-1731, 2016.","DOI":"10.1183\/13993003.02115-2015"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370: 2071-2082, 2014.","DOI":"10.1056\/NEJMoa1402584"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Newton CA, Batra K, Torrealba J, et al. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur Respir J 48: 1710-1720, 2016.","DOI":"10.1183\/13993003.00308-2016"},{"key":"18","unstructured":"18. Justet A, Thabut G, Manali E, et al. Safety and efficacy of pirfenidone in patients carrying telomerase complex mutation. Eur Respir J. Forthcoming."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Newton CA, Zhang D, Oldham JM, et al. Telomere length and use of immunosuppressive medications in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 200: 336-347, 2019.","DOI":"10.1164\/rccm.201809-1646OC"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tokman S, Singer JP, Devine MS, et al. Clinical outcomes of lung transplant recipients with telomerase mutations. J Heart Lung Transplant 34: 1318-1324, 2015.","DOI":"10.1016\/j.healun.2015.05.002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Silhan LL, Shah PD, Chambers DC, et al. Lung transplantation in telomerase mutation carriers with pulmonary fibrosis. Eur Respir J 44: 178-187, 2014.","DOI":"10.1183\/09031936.00060014"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Townsley DM, Dumitriu B, Young NS. Danazol treatment for telomere diseases. N Engl J Med 375: 1095-1096, 2016.","DOI":"10.1056\/NEJMc1607752"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/8\/60_5143-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T03:28:30Z","timestamp":1669606110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/8\/60_5143-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5143-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]}}}